Silk Nanoparticles: A Natural Polymeric Platform for Nitric Oxide Delivery in Biomedical Applications
Source abstract
Abstract
In this study, the preparation and characterization of nitric oxide (NO) releasing silk fibroin nanoparticles (SF NPs) are described for the first time. S-Nitroso-N-acetylpenicillamine (SNAP)-loaded SF NPs (SNAP-SF NPs) were prepared via an antisolvent/self-assembling method by adding a SNAP/ethanol solution to an aqueous SF solution and freeze-thawing. The prepared SNAP-SF NPs had a diameter ranging from 300 to 400 nm and an overall negative charge of −28.76 ± 0.73 mV. Among the different SNAP/SF ratios tested, the highest encapsulation efficiency (18.3 ± 1.3%) and loading capacity (9.1 ± 0.6%) values were attributed to the 1:1 ratio. The deconvolution of the amide I band in the FTIR spectra of SF NPs and SNAP-SF NPs showed an increase in the β-sheet content for SNAP-SF NPs, confirming the hydrophobic interactions between SNAP and silk macromolecules. SNAP-SF NPs released up to 1.31 ± 0.02 × 10–10 mol min–1 mg–1 NO over a 24 h period. Moreover, SNAP-SF NPs showed concentration-dependent antibacterial effects against methicillin-resistant Staphylococcus aureus and Escherichia coli. Furthermore, they did not elicit any marked cytotoxicity against 3T3 mouse fibroblast cells at concentrations equal to or below 2 mg/mL. Overall, these results demonstrated that SNAP-SF NPs have great potential to be used as a NO delivery platform for biomedical applications such as tissue engineering and wound healing, where synergistic properties of SF and NO are desired.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Silk-based biomaterials and applications · Electrospun Nanofibers in Biomedical Applications · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemical, Materials and Biomedical Engineering, University of Georgia, Athens, Georgia 30602, United States
Funding
University of Georgia
References (66)
Show source-provided references
1. 10.1016/j.bsbt.2015.08.00310.1016/j.bsbt.2015.08.003 ↗
2. 10.1016/j.biopha.2016.11.12510.1016/j.biopha.2016.11.125 ↗
3. 10.1038/s41598-017-14012-910.1038/s41598-017-14012-9 ↗
4. Liang H. · Future Sci. OA · 2015 · 110.4155/fso.15.54 ↗
5. 10.1002/jbm.b.3406510.1002/jbm.b.34065 ↗
6. 10.1039/c6bm00074f10.1039/c6bm00074f ↗
7. 10.1038/jid.2009.14910.1038/jid.2009.149 ↗
8. 10.1038/sj.bjp.070722410.1038/sj.bjp.0707224 ↗
9. Wang P. G. · 200510.1002/3527603751 ↗
10. 10.1002/adfm.20110170710.1002/adfm.201101707 ↗
11. 10.1021/acs.jpca.6b0223010.1021/acs.jpca.6b02230 ↗
12. 10.1016/j.biomaterials.2013.05.06310.1016/j.biomaterials.2013.05.063 ↗
13. 10.1016/j.niox.2004.09.00510.1016/j.niox.2004.09.005 ↗
14. 10.1111/j.1365-2133.2004.06213.x10.1111/j.1365-2133.2004.06213.x ↗
15. 10.1002/term.35310.1002/term.353 ↗
16. 10.1002/smll.20120045810.1002/smll.201200458 ↗
17. 10.1016/j.biomaterials.2004.06.00610.1016/j.biomaterials.2004.06.006 ↗
18. 10.1016/j.jconrel.2015.02.00710.1016/j.jconrel.2015.02.007 ↗
19. 10.1039/b912493b10.1039/b912493b ↗
20. 10.1016/j.jconrel.2015.12.05610.1016/j.jconrel.2015.12.056 ↗
21. 10.2174/15734131380511784810.2174/157341313805117848 ↗
22. 10.1002/jbm.a.3523910.1002/jbm.a.35239 ↗
23. 10.2147/IJN.S8219910.2147/IJN.S82199 ↗
24. 10.1080/15583724.2018.143754710.1080/15583724.2018.1437547 ↗
25. 10.1002/app.4664310.1002/app.46643 ↗
26. 10.1016/j.reactfunctpolym.2020.10450110.1016/j.reactfunctpolym.2020.104501 ↗
27. 10.3390/pharmaceutics1110049410.3390/pharmaceutics11100494 ↗
28. 10.1016/j.colsurfb.2018.08.02810.1016/j.colsurfb.2018.08.028 ↗
29. 10.1007/s10853-018-2635-310.1007/s10853-018-2635-3 ↗
30. 10.1016/j.ijpharm.2017.02.00510.1016/j.ijpharm.2017.02.005 ↗
31. 10.1039/c7sm01631j10.1039/c7sm01631j ↗
32. 10.1002/jbm.a.3653710.1002/jbm.a.36537 ↗
33. 10.1016/j.nano.2017.07.01210.1016/j.nano.2017.07.012 ↗
34. 10.1039/c7tb03113k10.1039/c7tb03113k ↗
35. 10.1021/acsbiomaterials.6b0045710.1021/acsbiomaterials.6b00457 ↗
36. 10.1021/acsbiomaterials.8b0045410.1021/acsbiomaterials.8b00454 ↗
37. 10.1021/acsami.6b1491210.1021/acsami.6b14912 ↗
38. 10.1016/j.biomaterials.2019.05.01210.1016/j.biomaterials.2019.05.012 ↗
39. 10.3390/antiox901008510.3390/antiox9010085 ↗
40. 10.3390/nano802012610.3390/nano8020126 ↗
41. 10.1080/1061186X.2017.136321210.1080/1061186X.2017.1363212 ↗
42. 10.1080/10717544.2020.173620810.1080/10717544.2020.1736208 ↗
43. 10.1016/j.jddst.2019.10129410.1016/j.jddst.2019.101294 ↗
44. 10.1038/nprot.2011.37910.1038/nprot.2011.379 ↗
45. 10.1021/acsami.7b0140810.1021/acsami.7b01408 ↗
46. 10.1039/b703139d10.1039/b703139d ↗
47. 10.1016/j.actbio.2018.04.02510.1016/j.actbio.2018.04.025 ↗
48. 10.1080/00914037.2018.155286110.1080/00914037.2018.1552861 ↗
49. 10.3390/ijms1603488010.3390/ijms16034880 ↗
50. 10.1002/jbm.a.3326510.1002/jbm.a.33265 ↗
51. 10.3390/ijms1712201210.3390/ijms17122012 ↗
52. 10.1021/acsami.5b0533510.1021/acsami.5b05335 ↗
53. 10.1016/j.actbio.2017.04.00110.1016/j.actbio.2017.04.001 ↗
54. 10.1074/jbc.271.31.1859610.1074/jbc.271.31.18596 ↗
55. Kevil C. G. · Curr. Opin. Invest. Drugs · 2010 · 11 · 1127
56. 10.1016/j.jconrel.2015.03.02010.1016/j.jconrel.2015.03.020 ↗
57. 10.1016/j.jconrel.2014.05.05910.1016/j.jconrel.2014.05.059 ↗
58. 10.1021/acsbiomaterials.7b0102110.1021/acsbiomaterials.7b01021 ↗
59. 10.1016/j.biomaterials.2010.09.05510.1016/j.biomaterials.2010.09.055 ↗
60. 10.1006/niox.1997.011810.1006/niox.1997.0118 ↗
61. 10.1016/j.jacc.2013.03.07010.1016/j.jacc.2013.03.070 ↗
62. 10.1016/j.actbio.2018.05.02510.1016/j.actbio.2018.05.025 ↗
63. 10.1093/toxsci/kft17910.1093/toxsci/kft179 ↗
64. 10.4161/viru.2032810.4161/viru.20328 ↗
65. 10.1016/j.actbio.2017.05.06110.1016/j.actbio.2017.05.061 ↗
66. 10.1016/j.actbio.2015.10.02110.1016/j.actbio.2015.10.021 ↗